179 parallel-and-distributed-computing-phd-"Meta" "Meta" Postdoctoral positions at University of Oxford in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Field
-
hepatitis and liver disease. This post is funded by the National Institute for Health and Care Research (NIHR) as part of a significant research programme that leverages large-scale healthcare datasets
-
) information-theoretic active learning, and c) capturing uncertainty in deep learning models (including large language models). The successful postholder will hold or be close to the completion of a PhD/DPhil in
-
with a PhD in Engineering (or close to completion) may apply. You will be responsible for: Design of the first reconfigurable robotic matter in collaboration with world-leading universities and
-
with the possibility of renewal. This project addresses the high computational and energy costs of Large Language Models (LLMs) by developing more efficient training and inference methods, particularly
-
inference attacks, to mitigate privacy leaks in MMFM. You will hold a PhD/DPhil (or be near completion) in a relevant discipline such as computer science, data science, statistics or mathematics; expertise in
-
institutions in the programme grant and with supporting industrial partners. About you You should possess a university PhD degree in mechanical engineering or a similar discipline, preferably with experience
-
), to develop systems that improve the efficacy of machine learning-based technologies for healthcare applications. You must hold a PhD (or be near completion) in a field such as AI, computer science, signal
-
dynamics and (at intermediate redshifts) strong gravitational lensing, thus preserving and extending the team’s lead in this field. Applicants should have a PhD (or close to completion) in (Astro) physics
-
annum inclusive of Oxford University weighting Potential to under fill at grade 06RS: £34,982-£40,855 per annum inclusive of Oxford University weighting The Department of Computer Science seeks to employ
-
Medicine, University of Oxford is to re-programme immune cells as part of a larger programme to develop novel therapeutics (viral vector and/or extracellular vesicle-based) for myocardial regeneration. Key